Pfizer starts, this Saturday (9), the delivery of vaccines against Covid-19 provided for in the second contract signed with the federal government. The first shipment of this agreement has 1,989,000 doses and will land at Viracopos International Airport, in Campinas (SP).
The flight will depart from Schiphol Airport in Amsterdam, Netherlands. The doses sent to Brazil are produced in two factories in the United States and one in Belgium.
“When they arrive in Brazil, the immunization agents are unloaded from the plane in up to 1 hour, depending on the quantity, and sent to the distribution center of the Ministry of Health, in Guarulhos”, informed Pfizer.
The second contract between Pfizer and the federal government, signed on May 14, provides 100 million more vaccines between October and December.
The American pharmacist has completed the delivery of 100 million predicted doses in the first contract with the country on Tuesday (5). The delivery of the last shipment of the first agreement took place late, after the flight with 1.1 million immunizations was rearranged for “logistics issues” last Sunday (3).
Pfizer has used Viracopos Airport for all deliveries to Brazil so far. The first shipment had 1 million doses and was received by the country on April 29, in a ceremony that was attended by the Minister of Health, Marcelo Queiroga.
According to Pfizer, the doses sent to Brazil are produced in two factories in the United States, Kalamazoo and McPherson, in addition to a factory in Europe, Purrs in Belgium.
- Scan, timer and release from the Internal Revenue Service in less than 30 minutes: how does the arrival of Covid-19 vaccines in Viracopos work
The logistics for delivering doses to the federal government is supported by the Federal Revenue Service, the Federal Police and the Federal Highway Police.
Also at the Viracopos terminal, Revenue teams developed a process called clearance over clouds, which allows for the anticipation of checking and release of cargo – the process between opening the plane’s cargo door and releasing the truck takes up to 20 minutes.
After the release in Viracopos, teams escort the doses by road to the Ministry of Health’s distribution center in Guarulhos (SP).
What vaccine is this? Pfizer Biotech
Shipments delivered by agreement with the Ministry of Health
Delivery by the Covax Facility consortium
In late May, the National Health Surveillance Agency (Anvisa) authorized new conservation and storage conditions for the Pfizer/Biontech vaccine, which can now be kept in temperature controlled between 2°C and 8°C for up to 31 days. The previous orientation was of five days.
Prior to the release of the vials for vaccination, Pfizer doses had to be stored in boxes at temperatures between -25°C and -15°C for a maximum of 14 days. Such conditions did not allow the vaccine to be sent to cities farther than 2:30 am from the state capital.
The Pfizer/BioNTech vaccine was the target of denial and controversy within the federal government. Also last year, three formal offers for the sale of 70 million doses were made by the company and were not answered by the Ministry of Health.
- Pfizer warned: doses reserved for Brazil would go to other countries if there was no response
Also in December, the Secretary of Health Surveillance at the Ministry of Health, Arnaldo Medeiros, ruled out the purchase of the vaccine because of the requirement to store it at low temperatures.
The vaccine was the first to obtain definitive sanitary registration by the National Health Surveillance Agency (Anvisa), in February this year.
The immunizing agent can be applied to people from 12 years of age, in two doses, with an interval of 21 days between them. The vaccine is the only one that can be applied to children under 18 in Brazil.
Initially, authorization from Anvisa allowed for use from 16 years of age onwards. But the agency authorized the change in the vaccine package insert in the country. However, there are still no prospects for vaccination of this age group in Brazil.
The adolescent age extension was approved after Pfizer presented studies that indicated the vaccine’s safety and efficacy for this group. The studies were developed outside Brazil and evaluated by the agency.
Pfizer expects to reach 89 million doses delivered by Sunday — Photo: Carla Cleto